Local view for "http://purl.org/linkedpolitics/eu/plenary/2010-11-22-Speech-1-153"

Predicate	Value (sorted: default)
rdf:type	lpv_eu:Speech2
dcterms:Date	"2010-11-22"^^xsd:date2
dcterms:Is Part Of	lp_eu:Information on medicinal products (Community code relating to medicinal products) - Information on medicinal products (Community procedures for the authorisation and supervision of medicinal products) (debate)2
dcterms:Language	"pt"^^xsd:language2
lpv:document identification number	"en.20101122.17.1-153"2
lpv:hasSubsequent	lp_eu:2010-11-22-Speech-1-1542
lpv:speaker	lp:António Fernando Correia De Campos2
lpv:spokenAs	member; S&D (2009-07-14--2014-06-30)3 member; IMCO (2009-07-16--2012-01-18)3 substitute; ITRE (2009-07-16--2012-01-18)3 substitute; Delegation to the EU-Russia Parliamentary Cooperation Committee (2009-09-16--2014-06-30)3 unknown; Parti socialiste (2009-07-14--2014-06-30)3 member; Delegation to the EU-Chile Joint Parliamentary Committee (2009-09-16--2012-04-11)3 member; Delegation to the Euro-Latin American Parliamentary Assembly (2009-09-16--2014-06-30)3
lpv:translated text	"Mr President, ladies and gentlemen, Commissioner Dalli, patients should have the right to know as much as possible about their illness and the medication available to treat it. Yet how can we distinguish information from advertising? Where and how is it possible to obtain objective and unbiased information? There are various interpretations of the texts currently in force, with the result that they need to be harmonised, strengthening the sovereignty of the individual. Information needs to be reliable, validated by the authorities, independent, accessible and targeted to an average, non-expert audience. The intention is to ensure more informed and responsible citizenship on the part of the end user. The deadline for the tacit approval of the European Medicines Agency (EMA) should be extended from 60 to 120 days. The requirement to state the reasons for a refusal lends weight to such rejections and gives balance to the final outcome. The EMA has a vital role as the preferred source of objective information. I would like to conclude by congratulating the rapporteur, Mr Fjellner, on his work, and by saying that I am delighted that he accepted almost all the proposals that I tabled as rapporteur for the opinion of the Committee on the Internal Market and Consumer Protection."@en1
lpv:videoURI	<go to Events_and_structure europarl>2

Named graphs describing this resource:

The resource appears as object in 2 triples

Context graph